Fezagepras sodium
Fezagepras sodium (Setogepram sodium salt) is an orally bioavailable small molecule that acts as a GPR40 agonist and a GPR84 antagonist/inverse agonist. It exhibits anti-fibrotic, anti-inflammatory, and anti-proliferative properties, making it a useful research tool for studying metabolic and inflammatory diseases in both in vitro and in vivo models.
Product Specifications
CAS Number
1254472-97-3
Product Name Alternative
Fezagepras sodium, GPR40, PBI-4050 sodium, PBI-4050 sodium salt, Setogepram sodium, Setogepram sodium salt
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.49% (May vary between batches)
Solubility
H2O:90 mg/mL (394.29 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.76 mM) ; DMSO:60 mg/mL (262.86 mM)
Smiles
CCCCCC1=CC (=CC=C1) CC (=O) [O-].[Na+]
Molecular Formula
C13H17NaO2
Molecular Weight
228.26
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Rxra sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
